Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • 11 - Legal and Regulatory Responses to Avoidable Adverse Medication Events, Part I: General Principles

  • Alan Merry, University of Auckland, Joyce Wahr, University of Minnesota
  • Book:
    Medication Safety during Anesthesia and the Perioperative Period
    Published online:
    09 April 2021
    Print publication:
    04 March 2021, pp 215-235

  • Summary

    Regulatory and legal processes relevant to avoidable adverse medication events have the potential to advance the cause of patient safety but it is expecting too much to believe that these processes alone will achieve the changes that need to be made, urgently and affordably, to reduce the persistently high rate of avoidable adverse medication events. Achieving the required change will require engagement by all concerned, from politicians, through directors of hospital boards and managers and clinical leaders of hospital services to front line clinicians – and also, of necessity, regulators and the legal profession. It has been argued elsewhere that there is an ethical imperative for greater engagement in patient safety,9 and we agree.